8-7828814-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_152251.4(DEFB106A):​c.59C>T​(p.Ala20Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000055 ( 0 hom., cov: 21)
Exomes 𝑓: 0.000010 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

DEFB106A
NM_152251.4 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.368
Variant links:
Genes affected
DEFB106A (HGNC:18088): (defensin beta 106A) Defensins form a family of antimicrobial and cytotoxic peptides made by neutrophils. Defensins are short, processed peptide molecules that are classified by structure into three groups: alpha-defensins, beta-defensins and theta-defensins. All beta-defensin genes are densely clustered in four to five syntenic chromosomal regions. Chromosome 8p23 contains at least two copies of the duplicated beta-defensin cluster. This duplication results in two identical copies of defensin, beta 106, DEFB106A and DEFB106B, in head-to-head orientation. This gene, DEFB106A, represents the more centromeric copy. [provided by RefSeq, Oct 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08229542).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DEFB106ANM_152251.4 linkuse as main transcriptc.59C>T p.Ala20Val missense_variant 2/2 ENST00000335186.3 NP_689464.1 Q8N104
LOC124901865 use as main transcriptn.7828814C>T intragenic_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DEFB106AENST00000335186.3 linkuse as main transcriptc.59C>T p.Ala20Val missense_variant 2/21 NM_152251.4 ENSP00000335307.2 Q8N104

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
8
AN:
144288
Hom.:
0
Cov.:
21
FAILED QC
Gnomad AFR
AF:
0.000102
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000212
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000520
GnomAD3 exomes
AF:
0.0000274
AC:
5
AN:
182668
Hom.:
0
AF XY:
0.0000513
AC XY:
5
AN XY:
97522
show subpopulations
Gnomad AFR exome
AF:
0.0000689
Gnomad AMR exome
AF:
0.000135
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000561
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000100
AC:
14
AN:
1400178
Hom.:
0
Cov.:
29
AF XY:
0.0000144
AC XY:
10
AN XY:
696148
show subpopulations
Gnomad4 AFR exome
AF:
0.0000953
Gnomad4 AMR exome
AF:
0.000136
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000192
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000520
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000554
AC:
8
AN:
144288
Hom.:
0
Cov.:
21
AF XY:
0.0000573
AC XY:
4
AN XY:
69832
show subpopulations
Gnomad4 AFR
AF:
0.000102
Gnomad4 AMR
AF:
0.000212
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000520
Alfa
AF:
0.0000484
Hom.:
0
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 02, 2024The c.59C>T (p.A20V) alteration is located in exon 2 (coding exon 2) of the DEFB106A gene. This alteration results from a C to T substitution at nucleotide position 59, causing the alanine (A) at amino acid position 20 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
12
DANN
Benign
0.96
DEOGEN2
Benign
0.031
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.013
N
M_CAP
Benign
0.00066
T
MetaRNN
Benign
0.082
T
MetaSVM
Benign
-0.95
T
PrimateAI
Benign
0.29
T
PROVEAN
Uncertain
-2.5
N
REVEL
Benign
0.12
Sift
Benign
0.054
T
Sift4G
Benign
0.27
T
Vest4
0.29
MutPred
0.20
Loss of catalytic residue at A20 (P = 0.0312);
MVP
0.014
MPC
2.0
ClinPred
0.046
T
GERP RS
-7.5
Varity_R
0.056
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs748520036; hg19: chr8-7686336; API